다코르(DXR) 주가 전망 및 기업 분석 - PER·배당·실적·목표주가·RSI·MACD

DXR

Daxor Corp

7월 27일 4:00 PM ET (한국 7/28 05:00)

$11.11

+0.66 ▲ +6.32%

다코르(DXR) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시가총액

$65M

스몰캡

P/E

6.1

저평가 구간

배당수익률

없음

52주 위치

41%

저점 +30% · 고점 -25%

애널리스트

적극 매수

Fundamental health

vs. Medical Instruments & Supplies 초소형주

수익성

Top 8%

성장

Top 64%

밸류에이션

Top 67%

재무 안정

Top 95%

Index ⓘ	-	P/E ⓘ	6.14	EPS (ttm) ⓘ	1.81	Insider Own ⓘ	48.94%	Shs Outstand ⓘ	5.1M	Perf Week ⓘ	1.87%
Market Cap ⓘ	0.06B	Forward P/E ⓘ	-	EPS next Y ⓘ	85.71%	Insider Trans ⓘ	0.07%	Shs Float ⓘ	3.0M	Perf Month ⓘ	7.66%
Enterprise Value ⓘ	0.06B	PEG ⓘ	-	EPS next Q ⓘ	-0.03	Inst Own ⓘ	6.76%	Short Float ⓘ	0.05%	Perf Quarter ⓘ	8.39%
Income ⓘ	0.01B	P/S ⓘ	129.76	EPS this Y ⓘ	-320%	Inst Trans ⓘ	10.4%	Short Ratio ⓘ	0.31	Perf Half Y ⓘ	-11.76%
Sales ⓘ	0.00B	P/B ⓘ	1.23	EPS next 5Y ⓘ	-	ROA ⓘ	22.19%	Short Interest ⓘ	0.00M	Perf YTD ⓘ	-24.68%
Book/sh ⓘ	9.07	P/C ⓘ	-	EPS past 3/5Y ⓘ	13.2% -	ROE ⓘ	22.45%	52W High ⓘ	-24.72% ($14.76)	Perf Year ⓘ	9.52%
Cash/sh ⓘ	0	P/FCF ⓘ	-	Sales past 3/5Y ⓘ	-	ROIC ⓘ	19.93%	52W Low ⓘ	29.79% ($8.56)	Perf 3Y ⓘ	15.49%
Dividend Est. ⓘ	-	EV/EBITDA ⓘ	7.07	EPS Y/Y TTM ⓘ	1682.38%	Gross Margin ⓘ	37.49%	Volatility(W/M) ⓘ	4.68% 3.38%	Perf 5Y ⓘ	19.46%
Dividend TTM ⓘ	-	EV/Sales ⓘ	129.98	Sales Y/Y TTM ⓘ	-97%	Oper. Margin ⓘ	1824.65%	ATR (14) ⓘ	0.53	Perf 10Y ⓘ	38.39%
Dividend Ex-Date ⓘ	2018/1/5	Quick Ratio ⓘ	0	EPS Q/Q ⓘ	329.28%	Profit Margin ⓘ	1821.48%	RSI (14) ⓘ	58.56	Recom ⓘ	1
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	0	Sales Q/Q ⓘ	-81.04%	SMA20 ⓘ	5.93% ($10.49)	Beta ⓘ	0.27	Target Price ⓘ	$23
Payout ⓘ	-	Debt/Eq ⓘ	0	Earnings ⓘ	2026/3/3	SMA50 ⓘ	7.39% ($10.35)	Rel Volume ⓘ	0.45	Prev Close ⓘ	$10.45
Employees ⓘ	-	LT Debt/Eq ⓘ	0	EPS/Sales Surpr. ⓘ	-	SMA200 ⓘ	-5.22% ($11.72)	Avg Volume(3M) ⓘ	0.00M	Price ⓘ	$11.11
IPO ⓘ	1983/7/25	Option/Short ⓘ	No/Yes			Trades ⓘ	117	Volume ⓘ	2,185	Change ⓘ	6.32%

Quarterly earnings trend SEC filings · USD

10.6

10.9

11.6

11.9

Revenue Net income 최근 분기: 매출 $0M (YoY -25%) · 순이익 $-4M (YoY -261%)

📊 Daxor Corp (DXR) Investment Analysis

What kind of company is Daxor Corp?

다코르(DXR) 가치주

Healthcare · Medical Instruments & Supplies

Small-Cap — Low Volume, High Volatility

A medical device and diagnostics company revolutionizing heart failure and critical care management through BVA-100, its proprietary precision blood volume measurement technology.

Learn more about Daxor Corp →

Market Cap

$0.1B

Approx. KRW 0.1 trillion

⚖️ 0% of Samsung Electronics

Market Cap Rank4804

IPO1983/07/25

Current Price$11.11 ≈ 15,221원

NASD · USA

Key Events

⏰ Upcoming events

🔔 Earnings release

The next release date has not been announced yet.

🎯 Ex-dividend date

No scheduled dividends

📜 Recent events

🔔 Earnings release 2026년 3월 3일 (화) · 장 시작 전

🎯 Ex-div 2018년 1월 5일 (금)

Is it profitable?

Profitable but financially weak

High debt load may weigh on results in a downturn

Profitability — How efficiently it makes money

Operating Margin

Profit kept from selling products and services (higher is better)

1824.7%

✓ 우수

My positionTop 5%

Low range Average High range

Medical Instruments & Supplies 초소형주 Median -41.1% · Top tier

💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수

Net Margin

Share of revenue left after taxes and interest are paid

1821.5%

✓ 우수

My positionTop 5%

Low range Average High range

Medical Instruments & Supplies 초소형주 Median -29.9% · Top tier

💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수

Gross Margin

Profit after subtracting raw-material costs only (signals product competitiveness)

37.5%

✓ 평균

My positionMid-range

Low range Average High range

Medical Instruments & Supplies 초소형주 Median 37.8% · Bottom 50%

💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)

ROE

Annual return earned on shareholders' equity (15%+ is strong)

22.4%

✓ 우수

My positionTop 5%

Low range Average High range

Healthcare 초소형주 Median -98.0% · Top tier

💡 일반적으로 15% 이상이면 우수 (단, 부채 레버리지 효과 주의)

ROA

Annual earnings relative to total company assets

22.2%

✓ 우수

My positionTop 5%

Low range Average High range

Healthcare 초소형주 Median -59.3% · Top tier

💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수

ROIC

Return generated per dollar invested in the business

19.9%

✓ 우수

My positionTop 5%

Low range Average High range

Healthcare 초소형주 Median -77.3% · Top tier

💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수

Financial health — Debt & liquidity burden

Debt-to-Equity (D/E)

Debt relative to equity (lower is healthier)

0.00

✓ Very low debt

My positionTop 5%

Low range Average High range

Medical Instruments & Supplies Median 0.26

💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)

Current Ratio

Liquid assets available to cover liabilities due within a year

0.00

✓ 위험

💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의

Quick Ratio

Liquid assets excluding inventory, available for immediate use

0.00

✓ 위험

💡 1.0 이상이면 안전, 0.5 미만이면 주의

* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Positive Outlook

Price targets, growth, and valuation are favorable

애널리스트 목표가

$23.00

현재가 대비 +107.0%

💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균

내년 EPS 예상 성장률

+85.7%

💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상

⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Insufficient historical earnings data

No analyzable past earnings releases have been collected yet.

Is it growing?

Average Growth

Mid-range within the industry

🔮 How much will it grow? (analyst forecasts)

This Year's EPS Outlook

Projected EPS growth rate for this year

-320.0%

매우 부진

My positionBottom 5%

Low range Average High range

가치주 초소형주 Median 7.1% · Bottom tier

Next Year's EPS Outlook

Projected EPS growth rate for next year (analyst consensus)

+85.7%

우수

My positionTop 25%

Low range Average High range

가치주 초소형주 Median 16.0% · Top 21%

📊 How much has it grown? (actual results)

Past 3-Year EPS

Actual average annual EPS growth over the past 3 years

+13.2%

양호

My positionMid-range

Low range Average High range

가치주 초소형주 Median 2.4% · Top 34%

⚡ Short-term momentum

QoQ Revenue

Revenue change from the previous quarter (short-term momentum)

-81.0%

매우 부진

My positionBottom 5%

Low range Average High range

가치주 초소형주 Median 5.3% · Bottom tier

* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -49%p below the market

DXR +19.5% · S&P 500 +68.3%

Excess return vs. market (price-based, ex-dividends)

5-year basis

vs S&P 500

-48.9%p

Significantly behind the market

vs Health Care (XLV)

-5.0%p

slightly behind the sector average

1-year basis

vs S&P 500

-6.5%p

slightly behind the market

vs Health Care (XLV)

-10.2%p

behind the sector average

Rank among peers

5-year return Top among peers Based on 18 peers

1-year return Top 11% Based on 23 peers

Current position within 52-week range

Low (-29.8%p) High (-24.7%p)

Current price is 29.8% above the 52-week low and 24.7% below the 52-week high

Recent risk (last 120 trading days)

Max drawdown

-28.7%

Annualized volatility

58.9%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

close
BB Upper
BB Mid
BB Lower
Tenkan
Kijun
Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🟢

Current diagnosis · 2026-07-27

Uptrend zone

Current price $11.11 above the midline ($10.64). Normal upward flow. Above the Ichimoku cloud (bullish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

✨

Current diagnosis · 2026-07-27

Golden cross — bullish reversal signal

MACD(0.121) crossed above Signal(0.114). Trend reversal possible; read as a buy entry point.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🟢

Current diagnosis · 2026-07-27

Bullish zone

RSI 54.9 (above the neutral level of 50). Buying pressure leads, supporting a steady rise. Stoch %K is also 53.8.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry

Cheap on Vs. Earnings·Vs. Assets·Vs. Cash Flow, Pricey on Vs. Sales

💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.

💵 Vs. Earnings Cheap

🏢 Vs. Assets Cheap

🧾 Vs. Sales Pricey

💧 Vs. Cash Flow Cheap

💵 Vs. Earnings

PER Price-to-Earnings Ratio

How expensive the price is vs. earnings — lower is cheaper

6.14x

✓ Very cheap

My positionTop 5%

Low range Average High range

Medical Instruments & Supplies median 35.22x · Top 1% — relatively cheap within the industry

💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)

🏢 Vs. Assets

PBR Price-to-Book Ratio

Price vs. the company's asset value — below 1 trades cheaper than assets

1.23x

✓ Cheap

My positionMid-range

Low range Average High range

Medical Instruments & Supplies 초소형주 median 1.95x · Around the industry average

💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)

🧾 Vs. Sales

PSR Price-to-Sales Ratio

Market cap vs. revenue — lower is cheaper relative to sales

129.76x

✓ Very pricey

My positionBottom 5%

Low range Average High range

Medical Instruments & Supplies 초소형주 median 2.38x · Bottom 1% — expensive within the industry

💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)

💧 Vs. Cash Flow

EV/EBITDA Enterprise Value Multiple

Total enterprise value ÷ operating cash earnings — a benchmark for M&A

7.07x

✓ Very cheap

My positionTop 5%

Low range Average High range

Medical Instruments & Supplies median 14.76x · Top 1% — relatively cheap within the industry

💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)

Analyst target price (reference)

$23.00 vs. current price +107.0%

* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.

As of: Recent snapshot · Peer group: Medical Instruments & Supplies

Who owns it?

Ownership flow is positive

Insider modest net buying +0.1% · Institutional net buying +10.4% · Short interest light 0.1%

📈 Recent trading flow (6 months)

🧑‍💼 Insiders (executives & directors)

+0.1%

Insiders little change

🏦 Institutions (funds & investors)

+10.4%

Institutions large net buying

💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.

👥 Holdings composition

🏦 Institutions 6.8%

Retail-led

Healthcare 초소형주 Median 14.2%

🧑‍💼 Insiders 48.9%

Founder/management large holders (strong skin-in-the-game)

Healthcare 초소형주 Median 16.1%

👤 Retail investors (estimated) 44.3%

Everyone excluding institutions and insiders

Institutions Insiders Retail (est.)

📉 Short-selling metrics

Short ratio

0.1%

Low — limited short-side pressure

Healthcare 초소형주 Median 3.9%

Past 90 days Little change

Short interest days to cover

0.3 days

Days needed to close short positions using average trading volume

🧮 Share count

Total shares outstanding 5.1M주

Float (tradable shares) 3.0M주

* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding DXR

ETFs with the highest weightings · 1 total shown

VTI

Vanguard Total Stock Market ETF

0.00%

$657.4B

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)

Sorted by market cap, largest first

Stock	Market Cap	PER	PBR	ROE	Dividend Yield	Change
DXR This Stock	$64.9M	6.1 ▲	1.2 ▲	22.45% ▲	-	+6.3%
LLY	$1.13T	43.1 ▼	36.2 ▼	107.64% ▲	0.58% ▼	+0.1%
JNJ	$640.9B	30.8 ▼	7.5 ▼	25.74% ▲	2.02% ▲	+1.0%
ABBV	$453.9B	126.7 ▼	-	15221.82% ▲	2.67% ▲	-0.9%
UNH	$379.3B	26.9 ▼	3.9 ▼	12.49% ▲	2.16% ▲	-0.7%
MRK	$323.0B	36.8 ▼	7.0 ▼	18.97% ▲	2.5% ▲	-0.2%
Sector Avg	-	26.1	2.7	-48.83%	1.23%	-

FAQ

What kind of company is 다코르(DXR)?

다코르(DXR) belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is the market cap of DXR?

The market cap of DXR is approximately $65M, ranking 4,804 within its sector.

What is the P/E ratio of DXR?

DXR has a P/E ratio of approximately 6.1x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for DXR?

DXR has recorded a 52-week high of $14.76 and a low of $8.56.

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.